RYSE announces partnership with DigitalHealth.London to invest in early stage digital health businesses

RYSE has partnered with DigitalHealth.London in a new venture which could pave the way for public-private collaborations in health and care. RYSE through its Early Stage Opportunity Fund, supported by DigitalHealth.London, seeks to support a number of promising early stage digital health businesses within the NHS or other healthcare delivery systems.

RYSE aims to review high calibre companies developing digital solutions that are innovative services or products and address identified health and care needs. The collaboration provides an opportunity for digital health innovations looking for funding to support large scale adoption across the NHS, but also for the creation of digital tools and applications that improve patient experiences, drive operational efficiency in the NHS and build long term value for investors.

Claudio D’Angelo, Managing Partner of RYSE commented, “RYSE is very excited to be working with DigitalHealth.London to identify and support early stage digital health businesses that have the potential to offer new solutions and reduce costs. The offering aims to address an investment or funding gap in the market largely overlooked by institutional and professional investors due to the time involved in undertaking due diligence on a number of early stage companies and their principals or founders. Combining our investment management expertise with the experience and networks of DigitalHealth.London, we are confident we will be able to make a tangible contribution to the digital health and care market.”

Yinka Makinde, Programme Director at DigitalHealth.London explained, “DigitalHealth.London’s extensive networks and intimate market knowledge of the health and care sector, particularly around digital solutions mean we are able to signpost RYSE toward innovations that we believe meet a need and offer real potential in providing positive and lasting impacts on the health outcomes for patients. In addition, we bring the highly regarded power of the Academic Health Science Networks (AHSNs) and their proven approach to brokering relationships that can support and facilitate the rapid scaling up of these products.”

RYSE seeks to invest from seed up to and including Series A and is looking to invest between £250,000 and £2,000,000 in a number of companies. Areas of focus in the digital health space include:

  • Telehealth and care – activity/fall monitoring, remote medication management, long-term condition monitoring and video consultation
  • mHealth – wearables or apps for medical or wellness and fitness
  • Health Analytics – genomics, precision medicine or data analytics such as imaging, health data, health status, population health, readmission rates, bed occupancy or procurement data
  • Digitised health systems – patient or provider held digital records or devices and diagnostics.

Early stage digital health businesses looking for funding are invited to apply. The application process opens today, 27 November 2017, and will run until 18 January 2018. You can see more details on the application process here.